The CDC’s vaccine advisors on Thursday maintained that respiratory syncytial virus immunization is only recommended for ...

This week, Roche RHHBY announced its third-quarter and nine-month results. Sanofi SNY confirmed that it is holding exclusive ...

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Sanofi and partner AstraZeneca recently increased production capacity for their RSV antibody shot, sales of which jumped ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the ...

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.

Recent findings from a multi-state study reveal that the RSV vaccine is approximately 80% effective in preventing severe ...

Respiratory syncytial virus, or RSV, typically presents as mild, with symptoms similar to the common cold for adults and ...

The RSV vaccine is unequivocally recommended for adults who are residents in skilled nursing and assisted living facilities.

On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more ...